These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16153869)

  • 41. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
    Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
    Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation of pH-measurement in platelet concentrates.
    van der Meer PF; van Zanten AP; Pietersz RN; Reesink HW
    Transfus Med; 2001 Feb; 11(1):49-54. PubMed ID: 11328572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
    Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
    Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.
    Bertolini F; Murphy S
    Transfusion; 1996 Feb; 36(2):128-32. PubMed ID: 8614962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
    Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
    J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently?
    Nguyen KA; Chavarin P; Arthaud CA; Cognasse F; Garraud O
    Blood Transfus; 2013 Jan; 11(1):152-3. PubMed ID: 22871820
    [No Abstract]   [Full Text] [Related]  

  • 49. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of washing solution on platelet counts following transfusion with twice-washed platelets: a single-patient experience.
    Tanaka Y; Ohishi K; Yonekawa T; Yodoya N; Iwamoto S; Nishioka Y; Tatara Y; Matsumoto T; Masuya M
    Transfus Med; 2010 Oct; 20(5):358-60. PubMed ID: 20456687
    [No Abstract]   [Full Text] [Related]  

  • 53. [Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients].
    Andreu G; Vasse J; Hervé F; Tardivel R; Semana G
    Transfus Clin Biol; 2007 May; 14(1):100-6. PubMed ID: 17524696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of platelet suspensions from whole blood in buffer. Description of a method which gives a large platelet yield.
    Schmidt KG; Rasmussen JW
    Scand J Haematol; 1979 Aug; 23(2):88-96. PubMed ID: 493879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
    Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
    Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of plateletpheresis on the Fresenius AS.TEC 204 and Haemonetics MCS 3p.
    Ranganathan S
    J Clin Apher; 2007 Feb; 22(1):1-4. PubMed ID: 17111420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring the pH of platelet concentrates.
    Ringwald J; Zimmermann R; Strasser E; Weiss D; Eckstein R
    Transfusion; 2006 May; 46(5):870-1; author reply 871-2. PubMed ID: 16686860
    [No Abstract]   [Full Text] [Related]  

  • 59. Storage in synthetic medium and leuko-depletion of platelet concentrates.
    Bertolini F; Rebulla P; Marangoni F; Porretti L; Sirchia G
    Vox Sang; 1994; 67 Suppl 3():155-8. PubMed ID: 7975483
    [No Abstract]   [Full Text] [Related]  

  • 60. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.